NCT07253506

Brief Summary

This study will include individuals aged 18-80 years who have been clinically diagnosed with stroke and have spent at least one month at home after discharge. Sociodemographic and clinical characteristics will be recorded. Functional status will be assessed using the Modified Rankin Scale, Brunnstrom Stages, and the Modified Barthel Index. Ambulation status will be documented with the Holden Scale. The scale will first be translated into Turkish and then back-translated into English by a bilingual expert whose native language is English. The Turkish version of the scale will be administered to patients. Two independent evaluators will apply the scale twice, one week apart. Validity will be examined by analyzing the relationship between the scale and the Stroke Impact Scale and the Treatment Burden Questionnaire

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
170

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 19, 2025

Completed
1 day until next milestone

Study Start

First participant enrolled

November 20, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

November 28, 2025

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 10, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 10, 2026

Completed
Last Updated

November 28, 2025

Status Verified

November 1, 2025

Enrollment Period

5 months

First QC Date

November 19, 2025

Last Update Submit

November 19, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • PETS-Stroke scale

    The primary measure, the PETS-Stroke scale, evaluates patients' experiences with treatment and self-management; its scoring system is based on subscale scores typically transformed to 0-100, with higher values reflecting greater perceived burden or difficulty in treatment and self-management.

    Baseline

Secondary Outcomes (4)

  • The Modified Rankin Scale

    Baseline

  • Modified Barthel Index

    Baseline

  • Stroke Impact Scale

    Baseline

  • Treatment Burden Questionnaire

    Baseline

Interventions

no intervention

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Clinical diagnosis of stroke (ischemic or hemorrhagic).

You may qualify if:

  • Clinical diagnosis of stroke (ischemic or hemorrhagic).
  • Having spent at least 1 month at home after hospital discharge (to capture post-acute home care/rehabilitation burden).
  • Community-dwelling individuals aged 18-80 years.
  • Adequate Turkish reading-writing and communication ability.
  • Ability to provide informed consent.
  • In cases of mild aphasia, ability to complete the questionnaire independently or with support.

You may not qualify if:

  • History of subarachnoid hemorrhage.
  • Inability to communicate effectively due to severe aphasia or severe cognitive impairment.
  • Terminal illness (life expectancy \< 6 months).
  • Inability to complete the questionnaire reliably due to a psychiatric disorder.
  • Acute phase (those hospitalized or before discharge).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul Physical Medicine Rehabilitation Training and Research Hospital

Istanbul, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
CROSS SECTIONAL
Target Duration
1 Week
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 19, 2025

First Posted

November 28, 2025

Study Start

November 20, 2025

Primary Completion

April 10, 2026

Study Completion

April 10, 2026

Last Updated

November 28, 2025

Record last verified: 2025-11

Locations